Back to User profile » Prof. Dr. Feng Gao
Papers published by Prof. Dr. Feng Gao:
Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis
Ye J, Deng G, Gao F
Drug Design, Development and Therapy 2018, 12:901-909
Published Date: 19 April 2018
Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?
Zheng C, Hu X, Zhao L, Hu M, Gao F
Drug Design, Development and Therapy 2017, 11:2957-2968
Published Date: 11 October 2017
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations
Hu MH, Zheng CL, Gao F
Drug Design, Development and Therapy 2016, 10:3983-3994
Published Date: 7 December 2016
4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression
Gao F, Du W, Zafar MI, Shafqat RA, Jian L, Cai Q, Lu FR
Drug Design, Development and Therapy 2015, 9:5727-5736
Published Date: 20 October 2015
Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells
Hu XF, Zafar MI, Gao F
Drug Design, Development and Therapy 2015, 9:4847-4860
Published Date: 21 August 2015
Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes
Zafar MI, Ai X, Shafqat RA, Gao F
Therapeutics and Clinical Risk Management 2015, 11:27-32
Published Date: 19 December 2014